275 related articles for article (PubMed ID: 17255135)
61. Malignancy in systemic lupus erythematosus.
Abu-Shakra M; Gladman DD; Urowitz MB
Arthritis Rheum; 1996 Jun; 39(6):1050-4. PubMed ID: 8651970
[TBL] [Abstract][Full Text] [Related]
62. A sharp rise in the incidence of Hodgkin's lymphoma in young adults in Israel.
Ariad S; Lipshitz I; Benharroch D; Gopas J; Barchana M
Isr Med Assoc J; 2009 Aug; 11(8):453-5. PubMed ID: 19891230
[TBL] [Abstract][Full Text] [Related]
63. Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort.
Urowitz MB; Gladman D; Ibañez D; Fortin P; Sanchez-Guerrero J; Bae S; Clarke A; Bernatsky S; Gordon C; Hanly J; Wallace D; Isenberg D; Ginzler E; Merrill J; Alarcón GS; Steinsson K; Petri M; Dooley MA; Bruce I; Manzi S; Khamashta M; Ramsey-Goldman R; Zoma A; Sturfelt G; Nived O; Maddison P; Font J; van Vollenhoven R; Aranow C; Kalunian K; Stoll T;
Arthritis Rheum; 2008 Feb; 59(2):176-80. PubMed ID: 18240193
[TBL] [Abstract][Full Text] [Related]
64. Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis.
Ni J; Qiu LJ; Hu LF; Cen H; Zhang M; Wen PF; Wang XS; Pan HF; Ye DQ
Lupus; 2014 Mar; 23(3):284-92. PubMed ID: 24429300
[TBL] [Abstract][Full Text] [Related]
65. Changing epidemiology and risk factors for gastrointestinal non-Hodgkin's lymphoma in a North American population: population-based study.
Andrews CN; John Gill M; Urbanski SJ; Stewart D; Perini R; Beck P
Am J Gastroenterol; 2008 Jul; 103(7):1762-9. PubMed ID: 18557717
[TBL] [Abstract][Full Text] [Related]
66. Long-term effects of high-dose chemotherapy and radiation for relapsed and refractory Hodgkin's lymphoma.
Goodman KA; Riedel E; Serrano V; Gulati S; Moskowitz CH; Yahalom J
J Clin Oncol; 2008 Nov; 26(32):5240-7. PubMed ID: 18809615
[TBL] [Abstract][Full Text] [Related]
67. Sex- and kindred-specific familial risk of non-Hodgkin's lymphoma.
Czene K; Adami HO; Chang ET
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2496-9. PubMed ID: 18006943
[TBL] [Abstract][Full Text] [Related]
68. Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort.
Urowitz MB; Gladman D; Ibañez D; Fortin P; Sanchez-Guerrero J; Bae S; Clarke A; Bernatsky S; Gordon C; Hanly J; Wallace D; Isenberg D; Ginzler E; Merrill J; Alarcon G; Steinsson K; Petri M; Dooley MA; Bruce I; Manzi S; Khamashta M; Ramsey-Goldman R; Zoma A; Sturfelt G; Nived O; Maddison P; Font J; van Vollenhoven R; Aranow C; Kalunian K; Stoll T; Buyon J
Lupus; 2007; 16(9):731-5. PubMed ID: 17728367
[TBL] [Abstract][Full Text] [Related]
69. Arteriosclerosis obliterans associated with anti-cardiolipin antibody/beta2-glycoprotein I antibodies as a strong risk factor for ischaemic heart disease in patients with systemic lupus erythematosus.
Nojima J; Masuda Y; Iwatani Y; Kuratsune H; Watanabe Y; Suehisa E; Takano T; Hidaka Y; Kanakura Y
Rheumatology (Oxford); 2008 May; 47(5):684-9. PubMed ID: 18375400
[TBL] [Abstract][Full Text] [Related]
70. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
[TBL] [Abstract][Full Text] [Related]
71. Systemic lupus and malignancies.
Bernatsky S; Kale M; Ramsey-Goldman R; Gordon C; Clarke AE
Curr Opin Rheumatol; 2012 Mar; 24(2):177-81. PubMed ID: 22227880
[TBL] [Abstract][Full Text] [Related]
72. Invasive fungal infections in patients with systemic lupus erythematosus: experience from affiliated hospitals of Catholic University of Korea.
Kim HJ; Park YJ; Kim WU; Park SH; Cho CS
Lupus; 2009 Jun; 18(7):661-6. PubMed ID: 19433470
[TBL] [Abstract][Full Text] [Related]
73. Descriptive epidemiology of non-Hodgkin's lymphoma in Oklahoma: 1997-2003.
Bliss A; Buriak S
J Okla State Med Assoc; 2008 Nov; 101(11):262-6. PubMed ID: 19113066
[TBL] [Abstract][Full Text] [Related]
74. Subarachnoid hemorrhage as a complication of systemic lupus erythematosus.
Baizabal Carvallo JF; Cantú Brito C; Estañol B; García Ramos GS
Cerebrovasc Dis; 2007; 24(2-3):301-4. PubMed ID: 17646695
[TBL] [Abstract][Full Text] [Related]
75. Incidence of lymphoma associated with underlying lupus: lessons learned from observational studies.
Bichile T; Petri M
Curr Opin Rheumatol; 2014 Mar; 26(2):111-7. PubMed ID: 24419748
[TBL] [Abstract][Full Text] [Related]
76. Systemic lupus erythematosus progressing to non-Hodgkin's lymphoma complicated by fatal hemophagocytic syndrome: case report.
Jeremić I; Dorđević-Kontić S; Nikolić M; Sefik-Bukilica M; Vujasinović-Stupar N; Bonači-Nikolić B
Acta Dermatovenerol Croat; 2012; 20(1):21-6. PubMed ID: 22507470
[TBL] [Abstract][Full Text] [Related]
77. Malignancy-associated remission of systemic lupus erythematosus maintained by autologous peripheral blood stem cell transplantation.
Schachna L; Ryan PF; Schwarer AP
Arthritis Rheum; 1998 Dec; 41(12):2271-2. PubMed ID: 9870885
[TBL] [Abstract][Full Text] [Related]
78. Risk for incident arterial or venous vascular events varies over the course of systemic lupus erythematosus.
Chang ER; Pineau CA; Bernatsky S; Neville C; Clarke AE; Fortin PR
J Rheumatol; 2006 Sep; 33(9):1780-4. PubMed ID: 16832849
[TBL] [Abstract][Full Text] [Related]
79. Systemic lupus erythematous and malignancy risk: a meta-analysis.
Cao L; Tong H; Xu G; Liu P; Meng H; Wang J; Zhao X; Tang Y; Jin J
PLoS One; 2015; 10(4):e0122964. PubMed ID: 25885411
[TBL] [Abstract][Full Text] [Related]
80. Characteristics of patients with systemic lupus erythematosus (SLE) and non-Hodgkin's lymphoma (NHL).
King JK; Costenbader KH
Clin Rheumatol; 2007 Sep; 26(9):1491-4. PubMed ID: 17297594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
